Public Views on Prescription Drug Costs: Regulation, Affordability and TrumpRx
(Authors: Audrey Kearney, Alex Montero, Julian Montalvo III, Isabelle Valdes, Ashley Kirzinger, and Liz Hamel for The Kaiser Family Foundation
Read More
Medicare Part D
Inflation Reduction Act tied to stronger medication adherence: Study
(By: Erica Cerutti for Becker’s Hospital Review) Cost-related medication nonadherence declined among Medicare enrollees following implementation of the Inflation Reduction
Read More
$13.4B premium hike in 2025 due to Medicare Advantage overpayments: Report
(By: Elizabeth Casolo for Becker’s Hospital Review) The Congressional Joint Economic Committee identified an additional $13.4 billion contributing to higher Medicare
Read MoreWhat Medicare’s Temporary Program Covering GLP-1s for Obesity Means for Beneficiaries
(By Juliette Cubanski for The Kaiser Family Foundation published March 9, 2026) The Centers for Medicare & Medicaid Services (CMS)
Read More
Medicare Part D enrollment in 2026: 5 things to know
(By: Elizabeth Casolo for Becker’s Hospital Review) Following the annual enrollment period for 2026, 56.1 million people — up from
Read MoreAnalyzing Changes in Medicare Part D Enrollment for 2026
(Authors: Juliette Cubanski, Nancy Ochieng, and Tricia Neuman for The Kaiser Family Foundation Published: Mar 3, 2026) For people with
Read MoreCan’t get a prescription renewed? Here’s how to cope with prior authorizations
(By Sarah Boden for NPR) A woman with multiple sclerosis wanted to be able to walk up the stairs without
Read MoreMedicare Advantage Enrollment Grew by About 1 Million People, Mainly Due to Special Needs Plans
(Authors: Jeannie Fuglesten Biniek, Meredith Freed, Nancy Ochieng, and Tricia Neuman for The Kaiser Family Foundation Published: Feb 23, 2026)
Read MoreShould Drug Companies Be Advertising to Consumers?
(By Paula Span for KFF Health News) Tamar Abrams had a lousy couple of years in 2022 and ’23. Both
Read More
12 drugs in shortage
(By: Ella Jeffries for Becker’s Hospital Review) The number of active drug shortages has declined sharply since June, according to
Read More